首页> 外文期刊>Journal of chemical theory and computation: JCTC >Accurate and Reliable Prediction of the Binding Affinities of Macrocycles to Their Protein Targets
【24h】

Accurate and Reliable Prediction of the Binding Affinities of Macrocycles to Their Protein Targets

机译:准确可靠地预测宏细胞与蛋白质目标的结合亲和力

获取原文
获取原文并翻译 | 示例
           

摘要

Macrocycles have been emerging as a very important drug class in the past few decades largely due to their expanded chemical diversity benefiting from advances in synthetic methods. Macrocyclization has been recognized as an effective way to restrict the conformational space of acyclic small molecule inhibitors with the hope of improving potency, selectivity, and metabolic stability. Because of their relatively larger size as compared to typical small molecule drugs and the complexity of the structures, efficient sampling of the accessible macrocycle conformational space and accurate prediction of their binding affinities to their target protein receptors poses a great challenge of central importance in computational macrocyde drug design. In this article, we present a novel method for relative binding free energy calculations between macrocydes with different ring sizes and between the macrocydes and their corresponding acyclic counterparts. We have applied the method to seven pharmaceutically interesting data sets taken from recent drug discovery projects including 33 macrocyclic ligands covering a diverse chemical space. The predicted binding free energies are in good agreement with experimental data with an overall root-mean-square error (RMSE) of 0.94 kcal/mol. This is to our knowledge the first time where the free energy of the macrocyclization of linear molecules has been directly calculated with rigorous physics-based free energy calculation methods, and we anticipate the outstanding accuracy demonstrated here across a broad range of target classes may have significant implications for macrocycle drug discovery.
机译:在过去的几十年中,宏细是在过去的几十年中作为一个非常重要的药物课程,这主要是由于他们的化学多样性促进了合成方法的进步。宏观循环已被认为是限制无环小分子抑制剂的构象空间的有效方法,希望提高效力,选择性和代谢稳定性。由于与典型的小分子药物相比,其尺寸相对较大,并且结构的复杂性,有效的取样可移植物的宏型构象空间和对其对靶蛋白受体的结合亲和力的准确预测构成了在计算宏核中核心重要性的巨大挑战药物设计。在本文中,我们提出了一种具有不同环尺寸和宏细胞与其相应的无环对应物之间的宏细胞之间的相对结合能量计算的新方法。我们已经将该方法应用于来自最近的药物发现项目的七种药学上有趣的数据集,包括33种覆盖各种化学空间的大环配体。预测的绑定能量与实验数据吻合良好,具有0.94kcal / mol的整体根均方误差(RMSE)。这是我们了解线性分子的宏次分子的自由能直接用严格的物理学的自由能量计算方法计算的第一次,我们预期跨越广泛的目标类别展示的出色准确性可能具有重要意义对宏观药物发现的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号